Literature DB >> 17551351

Age of onset of mental disorders: a review of recent literature.

Ronald C Kessler1, G Paul Amminger, Sergio Aguilar-Gaxiola, Jordi Alonso, Sing Lee, T Bedirhan Ustün.   

Abstract

PURPOSE OF REVIEW: The aim of this article is to review recent epidemiological research on age-of-onset of mental disorders, focusing on the WHO World Mental Health surveys. RECENT
FINDINGS: Median and inter-quartile range (IQR; 25th-75th percentiles) of age-of-onset is much earlier for phobias (7-14, IQR 4-20) and impulse-control disorders (7-15; IQR 4-35) than other anxiety disorders (25-53, IQR 15-75), mood disorders (25-45, IQR 17-65), and substance disorders (18-29, IQR 16-43). Although less data exist for nonaffective psychosis, available evidence suggests that median age-of-onset is in the range late teens through early 20s. Roughly half of all lifetime mental disorders in most studies start by the mid-teens and three quarters by the mid-20s. Later onsets are mostly secondary conditions. Severe disorders are typically preceded by less severe disorders that are seldom brought to clinical attention.
SUMMARY: First onset of mental disorders usually occur in childhood or adolescence, although treatment typically does not occur until a number of years later. Although interventions with early incipient disorders might help reduce severity-persistence of primary disorders and prevent secondary disorders, additional research is needed on appropriate treatments for early incipient cases and on long-term evaluation of the effects of early intervention on secondary prevention.

Entities:  

Mesh:

Year:  2007        PMID: 17551351      PMCID: PMC1925038          DOI: 10.1097/YCO.0b013e32816ebc8c

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  41 in total

1.  The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations.

Authors:  Philip C Kendall; Ronald C Kessler
Journal:  J Consult Clin Psychol       Date:  2002-12

2.  A controlled study of behavioral inhibition in children of parents with panic disorder and depression.

Authors:  J F Rosenbaum; J Biederman; D R Hirshfeld-Becker; J Kagan; N Snidman; D Friedman; A Nineberg; D J Gallery; S V Faraone
Journal:  Am J Psychiatry       Date:  2000-12       Impact factor: 18.112

3.  [Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study].

Authors:  Josep M Haro; Concepció Palacín; Gemma Vilagut; Montse Martínez; Mariola Bernal; Inma Luque; Miquel Codony; Montse Dolz; Jordi Alonso
Journal:  Med Clin (Barc)       Date:  2006-04-01       Impact factor: 1.725

4.  The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Howard Birnbaum; Olga Demler; Ian R H Falloon; Elizabeth Gagnon; Margaret Guyer; Mary J Howes; Kenneth S Kendler; Lizheng Shi; Ellen Walters; Eric Q Wu
Journal:  Biol Psychiatry       Date:  2005-07-14       Impact factor: 13.382

5.  Evaluating two brief substance-use interventions for mandated college students.

Authors:  Helene R White; Thomas J Morgan; Lisa A Pugh; Katarzyna Celinska; Erich W Labouvie; Robert J Pandina
Journal:  J Stud Alcohol       Date:  2006-03

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology.

Authors: 
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

8.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

Review 9.  Epidemiology of ADHD in school-age children.

Authors:  L Scahill; M Schwab-Stone
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2000-07

10.  Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults.

Authors:  K A Christie; J D Burke; D A Regier; D S Rae; J H Boyd; B Z Locke
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

View more
  650 in total

Review 1.  The Netrin-1/DCC Guidance Cue Pathway as a Molecular Target in Depression: Translational Evidence.

Authors:  Angélica Torres-Berrío; Giovanni Hernandez; Eric J Nestler; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2020-05-11       Impact factor: 13.382

2.  Distinctions in Behavioral Impulsivity: Implications for Substance Abuse Research.

Authors:  Donald M Dougherty; Charles W Mathias; Dawn M Marsh-Richard; R Michael Furr; Sylvain O Nouvion; Michael A Dawes
Journal:  Addict Disord Their Treat       Date:  2009-06-01

3.  Stability of early identified aggressive victim status in elementary school and associations with later mental health problems and functional impairments.

Authors:  Linnea R Burk; Jeffrey M Armstrong; Jong-Hyo Park; Carolyn Zahn-Waxler; Marjorie H Klein; Marilyn J Essex
Journal:  J Abnorm Child Psychol       Date:  2011-02

4.  Childhood adversities and adult psychopathology in the WHO World Mental Health Surveys.

Authors:  Ronald C Kessler; Katie A McLaughlin; Jennifer Greif Green; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky; Sergio Aguilar-Gaxiola; Ali Obaid Alhamzawi; Jordi Alonso; Matthias Angermeyer; Corina Benjet; Evelyn Bromet; Somnath Chatterji; Giovanni de Girolamo; Koen Demyttenaere; John Fayyad; Silvia Florescu; Gilad Gal; Oye Gureje; Josep Maria Haro; Chi-Yi Hu; Elie G Karam; Norito Kawakami; Sing Lee; Jean-Pierre Lépine; Johan Ormel; José Posada-Villa; Rajesh Sagar; Adley Tsang; T Bedirhan Ustün; Svetlozar Vassilev; Maria Carmen Viana; David R Williams
Journal:  Br J Psychiatry       Date:  2010-11       Impact factor: 9.319

5.  Youth Early-intervention Study (YES) - group interventions targeting social participation and physical well-being as an adjunct to treatment as usual: study protocol for a randomized controlled trial.

Authors:  Lillian Jean Gehue; Elizabeth Scott; Daniel Francis Hermens; Jan Scott; Ian Hickie
Journal:  Trials       Date:  2015-08-05       Impact factor: 2.279

6.  Higher Peripheral Inflammatory Signaling Associated With Lower Resting-State Functional Brain Connectivity in Emotion Regulation and Central Executive Networks.

Authors:  Robin Nusslock; Gene H Brody; Casey C Armstrong; Ann L Carroll; Lawrence H Sweet; Tianyi Yu; Allen W Barton; Emily S Hallowell; Edith Chen; James P Higgins; Todd B Parrish; Lei Wang; Gregory E Miller
Journal:  Biol Psychiatry       Date:  2019-05-01       Impact factor: 13.382

7.  Biobehavioral indicators of social fear in young children with fragile X syndrome.

Authors:  Bridgette L Tonnsen; Svetlana V Shinkareva; Sara C Deal; Deborah D Hatton; Jane E Roberts
Journal:  Am J Intellect Dev Disabil       Date:  2013-11

8.  Treatment History of Youth At-Risk for Serious Mental Illness.

Authors:  Megan S Farris; Glenda MacQueen; Benjamin I Goldstein; JianLi Wang; Sidney H Kennedy; Signe Bray; Catherine Lebel; Jean Addington
Journal:  Can J Psychiatry       Date:  2018-08-02       Impact factor: 4.356

9.  Demographic and functional differences among social security disability claimants.

Authors:  Molly Marino; Pengsheng Ni; Lewis Kazis; Diane Brandt; Alan Jette
Journal:  Qual Life Res       Date:  2021-02-21       Impact factor: 4.147

10.  Female rats are resistant to the long-lasting neurobehavioral changes induced by adolescent stress exposure.

Authors:  Katharina Klinger; Felipe V Gomes; Millie Rincón-Cortés; Anthony A Grace
Journal:  Eur Neuropsychopharmacol       Date:  2019-07-29       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.